Summary characteristics of primary studies in the selected systematic reviews.
| Region of primary studies . | Number of articles (N = 37*) . |
|---|---|
| North America | 30 |
| South America | 9 |
| Europe | 28 |
| Asia | 15 |
| Africa | 4 |
| Oceania | 19 |
| Setting | |
| Primary care | 33 |
| General Practice | 33 |
| Family Medicine | 7 |
| Community health | 13 |
| Other (academic setting, one stop clinics, secondary care, paediatric practice (immunizations), virtual settings, and population-based screening programs)). | 19 |
| Cancer site | |
| Breast | 14 |
| Colorectal | 18 |
| Cervical | 13 |
| Lung | 9 |
| Prostate | 8 |
| Skin | 4 |
| Other (ovarian, melanoma, bladder, haematologic, head and neck, brain, lymphoma, leukaemia and myeloma.) | 7 |
| Multiple (but not specified) | 5 |
| Not reported | 8 |
| Region of primary studies . | Number of articles (N = 37*) . |
|---|---|
| North America | 30 |
| South America | 9 |
| Europe | 28 |
| Asia | 15 |
| Africa | 4 |
| Oceania | 19 |
| Setting | |
| Primary care | 33 |
| General Practice | 33 |
| Family Medicine | 7 |
| Community health | 13 |
| Other (academic setting, one stop clinics, secondary care, paediatric practice (immunizations), virtual settings, and population-based screening programs)). | 19 |
| Cancer site | |
| Breast | 14 |
| Colorectal | 18 |
| Cervical | 13 |
| Lung | 9 |
| Prostate | 8 |
| Skin | 4 |
| Other (ovarian, melanoma, bladder, haematologic, head and neck, brain, lymphoma, leukaemia and myeloma.) | 7 |
| Multiple (but not specified) | 5 |
| Not reported | 8 |
*The total number of studies in each category may exceed 37, as each systematic review could report multiple factors within a single category. For example, a review might include primary studies from multiple regions, address more than one cancer site, or cover various relevant settings.
Summary characteristics of primary studies in the selected systematic reviews.
| Region of primary studies . | Number of articles (N = 37*) . |
|---|---|
| North America | 30 |
| South America | 9 |
| Europe | 28 |
| Asia | 15 |
| Africa | 4 |
| Oceania | 19 |
| Setting | |
| Primary care | 33 |
| General Practice | 33 |
| Family Medicine | 7 |
| Community health | 13 |
| Other (academic setting, one stop clinics, secondary care, paediatric practice (immunizations), virtual settings, and population-based screening programs)). | 19 |
| Cancer site | |
| Breast | 14 |
| Colorectal | 18 |
| Cervical | 13 |
| Lung | 9 |
| Prostate | 8 |
| Skin | 4 |
| Other (ovarian, melanoma, bladder, haematologic, head and neck, brain, lymphoma, leukaemia and myeloma.) | 7 |
| Multiple (but not specified) | 5 |
| Not reported | 8 |
| Region of primary studies . | Number of articles (N = 37*) . |
|---|---|
| North America | 30 |
| South America | 9 |
| Europe | 28 |
| Asia | 15 |
| Africa | 4 |
| Oceania | 19 |
| Setting | |
| Primary care | 33 |
| General Practice | 33 |
| Family Medicine | 7 |
| Community health | 13 |
| Other (academic setting, one stop clinics, secondary care, paediatric practice (immunizations), virtual settings, and population-based screening programs)). | 19 |
| Cancer site | |
| Breast | 14 |
| Colorectal | 18 |
| Cervical | 13 |
| Lung | 9 |
| Prostate | 8 |
| Skin | 4 |
| Other (ovarian, melanoma, bladder, haematologic, head and neck, brain, lymphoma, leukaemia and myeloma.) | 7 |
| Multiple (but not specified) | 5 |
| Not reported | 8 |
*The total number of studies in each category may exceed 37, as each systematic review could report multiple factors within a single category. For example, a review might include primary studies from multiple regions, address more than one cancer site, or cover various relevant settings.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
